EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Three Component One-Pot Synthesis and Antiproliferative Activity of New [1,2,4]Triazolo[4,3-a]pyrimidines

Manel Ben Hassen, Dhouha Msalbi, Badr Jismy iD, Fares Elghali iD, Sami Aifa iD, Hassan Allouchi, Mohamed Abarbri iD, Fakher Chabchoub iD

Molecules · 05.05.2023 · 28 (9) · 3917

DOI: 10.3390/molecules28093917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 05.05.2023. Verfasst von Manel Ben Hassen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Chemistry: Heterocycles, Lipids, and Polymers, Faculty of Sciences of Sfax, University of Sfax, Sfax 3000, Tunisia. Hauptthemen laut MEDLINE: Pyrimidines, Antineoplastic Agents. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of new [1,2,4]triazolo[4,3-a]pyrimidine derivatives was prepared using a one-pot three-component synthesis from 5-amino-1-phenyl-1H-1,2,4-triazoles, aromatic aldehydes and ethyl acetoacetate. The compound structures were confirmed by IR, 1H-NMR, 13C-NMR, HRMS and X-ray analyses. The biological activity of these compounds as antitumor agents was evaluated. Their antitumor activities against cancer cell lines (MDA-MB-231 and MCF-7) were tested by the MTT in vitro method. Among them, compounds 4c and 4j displayed the best antitumor activity with IC50 values of 17.83 μM and 19.73 μM against MDA-MB-231 and MCF-7 cell lines, respectively, compared to the Cisplatin reference.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesAntineoplastic AgentsHumansCisplatinMCF-7 CellsMagnetic Resonance SpectroscopyDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationCell Line, TumorMolecular Structure

Stichwörter der Autor:innen

antitumoralbreast cancermulticomponent reactionone-pot reactiontriazolopyrimidine

Substanzen

PyrimidinesAntineoplastic AgentsCisplatin

Autor:innen und Institutionen

  • Laboratory of Applied Chemistry: Heterocycles, Lipids, and Polymers, Faculty of Sciences of Sfax, University of Sfax, Sfax 3000, Tunisia.
  • Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax 3018, Tunisia.
  • Laboratory of Physico-Chemistry of Materials and Electrolytes for Energy (PCM2E), Faculty of Science and Technology, University of Tours, 37200 Tours, France.
  • Faculty of Pharmacy, University of Tours, 37200 Tours, France.

ORCID-Profile: Badr Jismy, Fares Elghali, Sami Aifa, Mohamed Abarbri, Fakher Chabchoub

Zitieren

APA

Ben Hassen, M., Msalbi, D., Jismy, B., Elghali, F., Aifa, S., Allouchi, H., Abarbri, M., & Chabchoub, F. (2023). Three Component One-Pot Synthesis and Antiproliferative Activity of New [1,2,4]Triazolo[4,3-a]pyrimidines. Molecules, 28(9), 3917. https://doi.org/10.3390/molecules28093917

Vancouver

Ben Hassen M, Msalbi D, Jismy B, Elghali F, Aifa S, Allouchi H, et al. Three Component One-Pot Synthesis and Antiproliferative Activity of New [1,2,4]Triazolo[4,3-a]pyrimidines. Molecules. 2023;28(9):3917. doi:10.3390/molecules28093917

BibTeX
@article{BenHassen2023,
  author = {Ben Hassen, Manel and Msalbi, Dhouha and Jismy, Badr and Elghali, Fares and Aifa, Sami and Allouchi, Hassan and Abarbri, Mohamed and Chabchoub, Fakher},
  title = {Three Component One-Pot Synthesis and Antiproliferative Activity of New [1,2,4]Triazolo[4,3-a]pyrimidines},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {9},
  pages = {3917},
  doi = {10.3390/molecules28093917}
}
Kostenlos starten →